Exchange: OTC·Updated 08:04 AM EDT

SPHDF Santhera Pharmaceuticals Holding AG

$23.25
$3.82
(16.42%)
Pre-Market
Prev Close $23.25
Mkt Cap$344.91M
Vol40.00

About SPHDF

Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
57

Bullish Sentiment

How do you feel about SPHDF?

Advertisement|Remove ads.